Competitive binding of pentraxins and IgM to newly exposed epitopes on late apoptotic cells

Cellular Immunology

Volumn 239, Issue 1, 2006, Pages 14-21

  Ciurana, Caroline L F ^a   Hack, C Erik ^a,b  

^a SANQUIN RESEARCH   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Apoptosis; IgM; Pentraxins; Phospholipids

Indexed keywords

C REACTIVE PROTEIN; IMMUNOGLOBULIN M; PENTRAXIN; PHOSPHOETHANOLAMINE; PHOSPHOLIPID; PHOSPHORYLCHOLINE; PHOSPHOSERINE;

ADSORPTION; APOPTOSIS; ARTICLE; BINDING AFFINITY; BINDING SITE; CELL FUNCTION; CELL MEMBRANE; CONTROLLED STUDY; HUMAN; HUMAN CELL; PHOSPHORYLATION; PRIORITY JOURNAL;

APOPTOSIS; BINDING, COMPETITIVE; C-REACTIVE PROTEIN; EPITOPES; HUMANS; IMMUNOGLOBULIN M; JURKAT CELLS; PROTEIN BINDING; SERUM AMYLOID P-COMPONENT; TIME FACTORS;

EID: 33745273276     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2006.02.006     Document Type: Article

References (29)

1. Cohen J.J. Apoptosis. Immunol.Today 14 (1993) 126
2. Saraste A. Morphologic criteria and detection of apoptosis. Herz. 24 (1999) 189
3. Balasubramanian K., and Schroit A.J. Aminophospholipid asymmetry: a matter of life and death. Annu. Rev. Physiol. 65 (2003) 701-734
4. Savill J., Fadok V., Henson P., and Haslett C. Phagocyte recognition of cells undergoing apoptosis. Immunol. Today 14 (1993) 131
5. Fishelson Z., Attali G., and Mevorach D. Complement and apoptosis. Mol. Immunol. Aug. 38 (2001) 207-219
6. Mevorach D., Mascarenhas J.O., Gershov D., and Elkon K.B. Complement-dependent clearance of apoptotic cells by human macrophages. J. Exp. Med. 188 (1998) 2313
7. Nauta A.J., Trouw L.A., Daha M.R., Tijsma O., Nieuwland R., Schwaeble W.J., Gingras A.R., Mantovani A., Hack E.C., and Roos A. Direct binding of C1q to apoptotic cells and cell blebs induces complement activation. Eur. J. Immunol. 32 (2002) 1726-1736
8. Taylor P.R., Carugati A., Fadok V.A., Cook H.T., Andrews M., Carroll M.C., Savill J.S., Henson P.M., Botto M., and Walport M.J. A hierarchical role for classical pathway complement proteins in the clearance of apoptotic cells in vivo. J. Exp. Med. 192 (2000) 359-366
9. Familian A., Zwart B., Huisman H.G., Rensink I., Roem D., Hordijk P.L., Aarden L.A., and Hack C.E. Chromatin-independent binding of serum amyloid P component to apoptotic cells. J. Immunol. 15 167 (2001) 647-654
10. Chang M.K., Binder C.J., Torzewski M., and Witztum J.L. From the cover: C-reactive protein binds to both oxidized LDL and apoptotic cells through recognition of a common ligand: phosphorylcholine of oxidized phospholipids. Proc. Natl. Acad. Sci. USA 99 (2002) 13043-13048
11. Bijl M., Horst G., Bijzet J., Bootsma H., Limburg P.C., and Kallenberg C.G. Serum amyloid P component binds to late apoptotic cells and mediates their uptake by monocyte-derived macrophages. Arthritis Rheum. 48 (2003) 248-254
12. Emsley J., White H.E., O'Hara B.P., Oliva G., Srinivasan N., Tickle I.J., Blundell T.L., Pepys M.B., and Wood S.P. Structure of pentameric human serum amyloid P component. Nature 367 (1994) 338
13. Schwalbe R.A., Dahlback B., Coe J.E., and Nelsestuen G.L. Pentraxin family of proteins interact specifically with phosphorylcholine and/or phosphorylethanolamine. Biochemistry 31 (1992) 4907
14. Volanakis J.E. Human C-reactive protein: expression, structure, and function. Mol. Immunol. 38 (2001) 189-197
15. Volanakis J.E., and Kaplan M.H. Specificity of C-reactive protein for choline phosphate residues of pneumococcal C-polysaccharide. Proc. Soc. Exp. Biol. Med. 136 (1971) 612
16. Mold C., Baca R., and Du Clos T.W. Serum Amyloid P Component and C-Reactive Protein Opsonize Apoptotic Cells for Phagocytosis through Fcgamma Receptors. J. Autoimmun. 19 (2002) 147-154
17. Gershov D., Kim S., Brot N., and Elkon K.B. C-Reactive protein binds to apoptotic cells, protects the cells from assembly of the terminal complement components, and sustains an antiinflammatory innate immune response: implications for systemic autoimmunity. J. Exp. Med. 192 (2000) 1353-1364
18. Kim S.J., Gershov D., Ma X., Brot N., and Elkon K.B. I-PLA(2) activation during apoptosis promotes the exposure of membrane lysophosphatidylcholine leading to binding by natural immunoglobulin M antibodies and complement activation. J. Exp. Med. 196 (2002) 655-665
19. Zwart B., Ciurana C., Rensink I., Manoe R., Hack C.E., and Aarden L.A. Complement activation by apoptotic cells occurs predominantly via IgM and is limited to late apoptotic (secondary necrotic) cells. J. Autoimmun. 37 (2004) 95-102
20. Chang M.K., Bergmark C., Laurila A., Horkko S., Han K.H., Friedman P., Dennis E.A., and Witztum J.L. Monoclonal antibodies against oxidized low-density lipoprotein bind to apoptotic cells and inhibit their phagocytosis by elicited macrophages: evidence that oxidation-specific epitopes mediate macrophage recognition. Proc. Natl. Acad. Sci. USA 96 (1999) 6353-6358
21. Shaw P.X., Horkko S., Chang M.K., Curtiss L.K., Palinski W., Silverman G.J., and Witztum J.L. Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity. J. Clin. Invest. 105 (2000) 1731-1740
22. Wolbink G.J., Brouwer M.C., Buysmann S., ten Berge I.J., and Hack C.E. CRP-mediated activation of complement in vivo: assessment by measuring circulating complement-C-reactive protein complexes. J. Immunol. 157 (1996) 473
23. Ying S.C., Gewurz A.T., Jiang H., and Gewurz H. Human serum amyloid P component oligomers bind and activate the classical complement pathway via residues 14-26 and 76-92 of the A chain collagen-like region of C1q. J. Immunol. 150 (1993) 169
24. Taketo M.M., and Sonoshita M. Phospolipase A(2) and apoptosis. Biochim. Biophys. Acta 1585 (2002) 72-76
25. Thompson D., Pepys M.B., and Wood S.P. The physiological structure of human C-reactive protein and its complex with phosphocholine. Structure Fold Des. 7 (1999) 169
26. Christner R.B., and Mortensen R.F. Binding of human serum amyloid P-component to phosphocholine. Arch. Biochem. Biophys. 314 (1994) 337
27. Cabiedes J., Cabral A.R., Lopez-Mendoza A.T., Cordero-Esperon H.A., Huerta M.T., and Alarcon-Segovia D. Characterization of anti-phosphatidylcholine polyreactive natural autoantibodies from normal human subjects. J. Autoimmun. 18 (2002) 181-190
28. Schenkein H.A., Berry C.R., Purkall D., Burmeister J.A., Brooks C.N., and Tew J.G. Phosphorylcholine-dependent cross-reactivity between dental plaque bacteria and oxidized low-density lipoproteins. Infect. Immun. 69 (2001) 6612-6617
29. Sorice M., Circella A., Misasi R., Pittoni V., Garofalo T., Cirelli A., Pavan A., Pontieri G.M., and Valesini G. Cardiolipin on the surface of apoptotic cells as a possible trigger for antiphospholipids antibodies. Clin. Exp. Immunol. 122 (2000) 277-284